Recent years have seen a surge in telehealth and online health delivery — from essential prescriptions to more discretionary health spending. Everyone from smaller boutique startups to Amazon want a slice of the pie. There’s a big debate in the medical community about so-called ‘asynchronous care’ — where a patient and doctor communicate through non-live online services. Pharmacists, already rattled by the retail revolution led by Chemist Warehouse, are also mad about this stuff.

Today we’re joined by Tim Doyle, founder of online healthcare company Eucalyptus, who gives a window into how this stuff works in Australia. And maybe beyond. (No promises.)

<p>Recent years have seen a surge in telehealth and online health delivery — from essential prescriptions to more discretionary health spending. Everyone from smaller boutique startups to Amazon want a slice of the pie. There’s a big debate in the medical community about so-called ‘asynchronous care’ — where a patient and doctor communicate through non-live online services. Pharmacists, already rattled by the retail revolution led by Chemist Warehouse, are also mad about this stuff.</p>
<p>Today we’re joined by <a href="https://www.linkedin.com/in/tim-doyle-11b48a14/">Tim Doyle</a>, founder of online healthcare company <a href="https://eucalyptus.vc/">Eucalyptus</a>, who gives a window into how this stuff works in Australia. And maybe beyond. (No promises.)</p>

The number one podcast about tech business and culture, from James "JR" Hennessy and Raph Dixon.

Advertisement